Healthcare marketing reclaims dedicated Effie category, raising bar for outcomes measurement

Did we save or extend lives? These are the questions that should define effectiveness.
Healthcare marketing must move beyond measuring reach and impressions to prove actual health impact.
Mark

So healthcare marketing gets its own category back at the Effies. Why does that matter? It's still just an award.

Mimi

It matters because it signals that the industry recognizes healthcare marketing as a distinct discipline with its own challenges and standards. You can't measure a migraine relief campaign the same way you measure a soft drink campaign.

Luke

But the piece doesn't actually say how long it's been absent, or why it was removed in the first place. We're told it's a "welcome return," but we don't know the history.

Mimi

Fair point. What we do know is that healthcare marketing has always competed and won in other categories. This is about creating dedicated space to ask the right questions.

Mark

What are the right questions?

Mimi

Did behavior change? Did people understand their health better? Did they make better decisions about their care? Did lives improve? Those are outcomes, not just outputs.

Luke

And can those actually be measured? The piece says "for many campaigns, can't be measured through sales data alone." That's a hedge. It doesn't say what the alternative measurement actually is.

Mimi

That's the challenge the category is supposed to push the industry to solve. Right now, most healthcare marketing is measured like any other marketing—reach, impressions, engagement. But those don't tell you if someone actually changed their behavior.

Mark

So the category is partly aspirational. It's saying: measure better.

Mimi

Exactly. It's raising the bar.

Luke

The piece is written by the CEO of Ward Marketing Group, which has a finalist in the category. That's worth noting. He has skin in the game.

Mimi

True. But his argument still holds: if healthcare marketing can prove it works, it deserves more investment. And if it gets more investment, health outcomes improve.

Mark

That's the chain. Proof leads to funding leads to better health.

Luke

In theory. But we don't actually see examples of campaigns that proved outcomes and then got more funding. That's the missing piece.

  • Healthcare marketing has long operated under constraints — scientific evidence requirements, strict regulation, and life-altering stakes — that set it apart from virtually every other marketing discipline.
  • For years, that distinctiveness went unacknowledged at the Effies, with healthcare campaigns folded into general categories where the most important questions about health outcomes were rarely the ones being asked.
  • The reinstatement of a dedicated Healthcare Marketing category creates formal space to interrogate what the work actually achieves: behavior change, improved health literacy, better-informed patient decisions, and measurable clinical impact.
  • The industry's current measurement culture — built around impressions, reach, and engagement — is being challenged to evolve toward outcome-based evidence that can prove campaigns moved the needle on real health results.
  • Ward Marketing Group and Organon's Maxalt Migraine Relief campaign are among this year's finalists, but the deeper contest is whether the category's return catalyzes a lasting shift in how healthcare marketing justifies and scales its investment.

After years of competing in general categories, healthcare marketing has reclaimed its own dedicated space at Australia's Effie Awards — a quiet but meaningful signal that the discipline has grown into something the broader industry can no longer treat as ordinary. The reinstatement, overseen by Advertising Council Australia, reflects a deepening recognition that campaigns which ask people to change health behaviors, seek treatment, or navigate complex medical decisions carry a weight of consequence that most marketing never touches. In honoring this work separately, the awards invite a harder question: not how many people saw the message, but whether lives were measurably changed by it.

Australia's Effie Awards have reinstated a dedicated Healthcare Marketing category after years of absence — a reinstatement that carries more weight than a simple administrative change. The Effies, run by Advertising Council Australia, are the country's foremost recognition of marketing that demonstrably works, and giving healthcare its own stage acknowledges something the industry has long understood about itself: this work is different.

Healthcare marketing operates inside a world where scientific evidence is foundational, regulation shapes every claim, and the decisions a campaign influences can alter the course of someone's life. The creativity required to move people in that context — and the discipline required to prove it worked — is not comparable to selling a product or building a brand in the conventional sense.

For years, healthcare campaigns competed alongside work from other sectors, winning recognition but never quite being asked the questions that matter most to the discipline. A dedicated category changes that. It creates space to ask whether a campaign changed behavior, improved understanding, helped people make better-informed decisions, or delivered outcomes that can be measured in health terms — not just in reach or impressions.

That shift in questioning is where the real opportunity now lies. The category's return is a beginning, not an achievement. The harder work ahead involves building a genuine evidence base around what healthcare marketing actually delivers — moving the industry away from output metrics and toward proof of real-world impact. The more compellingly that case can be made, the stronger the argument for sustained investment, and the greater the potential to improve health outcomes at scale.

Ward Marketing Group and Organon are among this year's finalists with their Maxalt Migraine Relief campaign. But the true measure of whether this category's reinstatement succeeds will not be counted in trophies. It will be counted in how many companies and agencies begin asking harder questions — and in how many patients and healthcare professionals find their decisions meaningfully shaped by the answers.

The Australian Effie Awards have brought back a category that had been missing for years: Healthcare Marketing. It's a reinstatement that matters more than it might sound, because it signals something about how the industry has matured and what it now demands of itself.

The Effies, run by Advertising Council Australia, are the country's primary mechanism for recognizing marketing campaigns that actually work. Judges—senior marketers, researchers, industry leaders—gather to assess work across dozens of categories, looking for demonstrable results. Tonight in Sydney, the industry will celebrate again. But this time, healthcare marketing has its own dedicated space on the stage.

The return acknowledges a simple truth: healthcare marketing operates under constraints and pressures that most other sectors don't face. The work happens inside a world where scientific evidence isn't optional—it's foundational. Regulation dictates what can be said and how. The stakes are not abstract. When a campaign asks someone to change their behavior, seek treatment, or make a decision about their care, that decision can alter the trajectory of their life. The creativity required to move people in that context, the understanding of human behavior needed, the relentless focus on what actually changes—these are not luxuries. They are the work itself.

For years, healthcare marketing competed in general categories alongside other sectors. The work was good, and it won recognition. But a dedicated category does something different. It creates space to ask questions that matter specifically to this discipline. Did the campaign change behavior? Did it improve understanding? Did it help people make better-informed decisions? Did it deliver measurable commercial results? Did it save or extend lives? These questions sit at the center of what healthcare marketing is supposed to do, and they are harder to answer than reach numbers or engagement metrics.

That's where the real opportunity lies now. The category's return is only a beginning. What comes next is the harder work: building a stronger evidence base around what healthcare marketing campaigns actually deliver. The industry has spent years measuring outputs—impressions, reach, engagement. Those numbers are easy to collect and easy to report. Outcomes are different. They require different measurement, different thinking, different kinds of proof. They demand that agencies and healthcare companies invest in understanding what changed in the world because of their work, not just how many people saw it.

Ward Marketing Group, alongside its client Organon, is a finalist this year for the Maxalt Migraine Relief campaign. But the real measure of success for this category won't be counted in trophies. It will be counted in how many healthcare companies and their agency partners begin to ask harder questions about effectiveness, in how much investment flows toward campaigns that can prove they moved the needle on actual health outcomes, and in how that investment compounds over time. The stronger the evidence of what healthcare marketing achieves, the stronger the case for funding it. The greater the funding, the greater the opportunity to improve health outcomes at scale. The winners, if this works, won't be the agencies or the companies. They'll be the healthcare professionals and the patients whose decisions and behaviors shift as a result.

We're often asking people to change entrenched behaviours, confront uncomfortable health realities, seek treatment or make complex decisions about their care.
— Stuart Black, CEO, Ward Marketing Group
The stronger the evidence of what healthcare marketing achieves, the stronger the case for investing in it.
— Stuart Black, CEO, Ward Marketing Group
Möchten Sie die ganze Geschichte? Das Original lesen bei Campaign Brief ↗
Kontakt FAQ